Hemoglobin and B-type natriuretic peptide preoperative values but not inflammatory markers, are associated with postoperative morbidity in cardiac surgery: A prospective cohort analytic study

Journal of Cardiothoracic Surgery

Volumn 8, Issue 1, 2013, Pages

  Hernández Leiva, Edgar ^a   Dennis, Rodolfo ^a   Isaza, Daniel ^a   Umaña, Juan Pablo ^a  

^a FUNDACIÓN CARDIOINFANTIL INSTITUTO DE CARDIOLOGÍA   (Colombia)

Author keywords

Cardiac surgery; Hemoglobin; Inotropic agents; Natriuretic peptides; Postoperative care

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; HEMOGLOBIN;

AGED; ARTICLE; BLOOD; FEMALE; HEART ATRIUM FIBRILLATION; HEART OUTPUT; HEART SURGERY; HOSPITAL READMISSION; HUMAN; LEUKOCYTE COUNT; MALE; METABOLISM; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIAC OUTPUT; CARDIAC SURGICAL PROCEDURES; FEMALE; HEMOGLOBINS; HUMANS; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES;

EID: 84879822281     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-8-170     Document Type: Article

References (44)

1. Warner CD, Weintraub WS, Craver JM, Jones EL, Gott JP, Guyton RA. Effect of cardiac surgery patient characteristics on patient outcomes from 1981 through 1995. Circulation 1997, 96:1575-1579. 10.1161/01.CIR.96.5.1575, 9315549.
2. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19,030 patients. Eur J Cardiothorac Surg 1999, 15(6):816-822. discusión 822-3, 10.1016/S1010-7940(99)00106-2, 10431864.
3. Gogbashian A, Sedrakyan A, Treasure T. EuroSCORE: a systematic review of international performance. Eur J Cardiothorac Surg 2004, 25:695-700. 10.1016/j.ejcts.2004.02.022, 15082269.
4. Farrokhyar F, Wang X, Kent R, Lamy A. Early mortality from off-pump and on-pump coronary bypass surgery in Canada: a comparison of the STS and the EuroSCORE risk prediction algorithms. Can J Cardiol 2007, 23:879-883. 10.1016/S0828-282X(07)70843-7, 2651365, 17876379.
5. O'Connor GT, Pluma SK, et al. Multivariate prediction of in-hospital mortality associated UIT coronary artery bypass garft surgery. Circulation 1992, 85:2110-2118. 10.1161/01.CIR.85.6.2110, 1591830.
6. Higgins TL, EStafanous FG, et al. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. JAMA 1992, 267:2344-2348. 10.1001/jama.1992.03480170070031, 1564774.
7. Tuman KJ, Mc Carthy RJ, et al. Morbidity and duration of ICU stay after cardiac surgery. Chest 1992, 102:36-44. 10.1378/chest.102.1.36, 1623792.
8. Horwich TB, Fonarow GC, et al. Anemia is associated with worse symptoms, greater inpairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002, 39:1780-1786. 10.1016/S0735-1097(02)01854-5, 12039491.
9. Lee PC, Kini AS, Ahsan CYC. Anemia is a independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 2004, 44:541-546. 10.1016/j.jacc.2004.04.047, 15358017.
10. Bell ML, Grunwald GK, Baltz JH. Does preoperative hemoglobina independently predict short-term outcomes after coronary artery baypass graft surgery?. Ann Thorac Surg 2008, 86:1415-23. 10.1016/j.athoracsur.2008.07.088, 19049724.
11. Pai JK, Pischon T, Ma JYC. Inflamatory markers and the risk of coronary heart disease in Men and women. N Engl J Med 2004, 351:2599-2610. 10.1056/NEJMoa040967, 15602020.
12. Pearson TA, Mensah GA, Alexander WYC. Markers of inflammation and cardiovascular disease. Circulation 2003, 107:499-511. 10.1161/01.CIR.0000052939.59093.45, 12551878.
13. Rodeheffer RJ. Measuring plasma B-type natriuretic peptide in heart failure. Good to go in 2004?. J Am Coll Cardiol 2004, 44:740-749.
14. De Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001, 345:1014-1021. 10.1056/NEJMoa011053, 11586953.
15. Richards AM, Nicholls MG, Espiner EA, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003, 107:2786-2792. 10.1161/01.CIR.0000070953.76250.B9, 12771003.
16. Win HK, Chang SM, Raizner M, et al. Percent change in B-type natriuretic peptide levels during treadmill exercise as a screening test for exercise-induced myocardial ischemia. Am Heart J 2005, 150:695-700. 10.1016/j.ahj.2004.12.003, 16209968.
17. Provenchere S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, et al. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 2006, 34:995-1000. 10.1097/01.CCM.0000206110.94385.C4, 16484891.
18. Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004, 43:1873-1879. 10.1016/j.jacc.2003.12.048, 15145114.
19. Kleinbaum DG, Klein M. Modelling strategy for assessing interaction and confounding, in: logistic regression 2002, 191-226. New York: Springer-Verlag.
20. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med. 1997, 336:1429-1434. 10.1056/NEJM199705153362006, 9145681.
21. Asher CR, Miller DP, Grimm RA, Cosgrove DM, Chung MK. Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery. Am J Cardiol. 1998, 82:892-895. 10.1016/S0002-9149(98)00498-6, 9781973.
22. Hogue CW, Creswell LL, Gutterman DD, Fleisher LA. American college of chest physicians. Epidemiology, mechanisms, and risks: American college of chest physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005, 128:9-16.
23. Aranki SF, Shaw DP, Adams DH, Rizzo RJYC. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation 1996, 94:390-397. 10.1161/01.CIR.94.3.390, 8759081.
24. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation. 2002, 106:75-80. 10.1161/01.CIR.0000021113.44111.3E, 12093773.
25. Wazni OM, Martin DO, Marrouche NFYC. Plasma B type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2004, 110:124-127. 10.1161/01.CIR.0000134481.24511.BC, 15210589.
26. Maganti MD, Rao V, Borger MA, Ivanov J, David TE. Predictors of low cardiac output syndrome after isolated aortic valve surgery. Circulation 2005, 112(9 Suppl):I448-I452.
27. Raymond I, Groenning BA, Hildebrandt PRYC. The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population. Heart 2003, 89:745-751. 10.1136/heart.89.7.745, 1767734, 12807847.
28. Yano Y, Katsuki A, Gabazza ECYC. Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria. J Clin Endocrinol Metab 1999, 84:2353-2356. 10.1210/jc.84.7.2353, 10404802.
29. Gæde P, Hildebrandt P, Hess GYC. Plasma N-terminal pro-brain natriuretic peptide as a major risk. Diabetologia 2005, 48:156-163. 10.1007/s00125-004-1607-0, 15619076.
30. Per-Henrik G, Thomas MC. Brain natriuretic peptide: microalbuminuria for cardiac disease and diabetes?. Diabetologia 2005, 48:3-5. 10.1007/s00125-004-1611-4, 15624097.
31. Cappabianca G, Paparella D, Visicchio GYC. Preoperative C-reactive protein predicts Mid-term outcome after cardiac surgery. Ann Thorac Surg 2006, 82:2170-2178. 10.1016/j.athoracsur.2006.06.039, 17126130.
32. Van der Harst P, Voors AA, Volbeda M. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting. Am J Cardiol 2006, 97:1697-1701. 10.1016/j.amjcard.2006.01.030, 16765116.
33. Gaudino M, Nasso G, Andreotti F, et al. Preoperative C reactive protein level and outcome following cardiac surgery. Eur J Cardiothorac Surg 2002, 22:521-526. 10.1016/S1010-7940(02)00436-0, 12297166.
34. Ahlsson A, Bodin L, Lundblad OHYC. Postoperative atrial fibrillation is Not correlated to C-reactive protein. Ann Thorac Surg 2007, 83:1332-1339. 10.1016/j.athoracsur.2006.11.047, 17383336.
35. Ridker PM, Rifai N, Pfeffer MAYC. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events (CARE) investigators. Circulation 1998, 98:839-844. 10.1161/01.CIR.98.9.839, 9738637.
36. Buffon A, Liuzzo G, Biasucci LMYC. Preprocedural serum levels of C- reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999, 34:1512-1521. 10.1016/S0735-1097(99)00348-4, 10551701.
37. Anand I, McMurray JJ, Whitmore JYC. Anemia and its relationship to clinical outcome in heart failure. Circulation 2004, 110:149-154. 10.1161/01.CIR.0000134279.79571.73, 15210591.
38. Kulier A, Levin J, Moser RYC. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007, 116:471-479. 10.1161/CIRCULATIONAHA.106.653501, 17620512.
39. Koch CG, Li L, Duncan AI, Mihaljevic TYC. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006, 81:1650-1657. 10.1016/j.athoracsur.2005.12.037, 16631651.
40. Koch CG, Li L, Duncan AIYC. Morbidity and mortality risk associated with Red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006, 34:1608-1616. 10.1097/01.CCM.0000217920.48559.D8, 16607235.
41. Hebert PC, Wells G, Blajchman MAYC. Transfusion requirements in critical care investigators, Canadian critical care trials group. A multicenter randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999, 340:409-417. 10.1056/NEJM199902113400601, 9971864.
42. Heiss MM. Risk of allogeneic transfusions. Br J Anaesth 1998, 81(suppl 1):16-19.
43. Banbury MK, Brizzio ME, Rajeswaran JYC. Transfusion increases the risk of postoperative infection after cardiovascular surgery. J Am Coll Surg 2006, 202:131-138. 10.1016/j.jamcollsurg.2005.08.028, 16377506.
44. Rao S, Jollis J, Harrington R, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004, 292:1555-1562. 10.1001/jama.292.13.1555, 15467057.